|
Agren et al., 1997*
|
Randomized Controlled Trial
|
Men (n=55)
Healthy students
Kuopio, Finland
Follow-up of 15 weeks
|
Seafood and n-3 supplementation
|
|
Cobiac et al., 1991*
|
Randomized Controlled Trial
|
Men (n=31)
Aged 30-60 years
Adelaide, South Australia
Mildly hyperlipidemic and normotensive
No history of heart disease, hypertension, bleeding disorders, liver or renal disorders, gout, diabetes, recent cerebrovascular accident, or obesity
No steroids, nonsteroidal anti-inflammatory drugs, aspirin, beta-blockers, allopurinol, or cardiac glycosides
No excessive alcohol intake (>40 g/day) or who smoked >20 cigarettes/day
Follow-up of 8 weeks
|
Seafood and n-3 supplementation
|
|
*Included in Balk E, Chung M, Lichtenstein A, Chew P, Kupelnick B, Lawrence A, DeVine D, Lau J. 2004. Effects of Omega-3 Fatty Acids on Cardiovascular Risk Factors and Intermediate Markers of Cardiovascular Disease. Summary, Evidence Report/Technology Assessment No. 93. (Prepared by the Tufts-New England Medical Center Evidence-based Practice Center, Boston, MA). AHRQ Publication No. 04-E010-1. Rockville, MD: Agency for Healthcare Research and Quality.
** N = Evidence of no association or no clear association; B = Evidence of a benefit.
|
